Cutaneous lymphomas are rare subtypes of non-Hodgkin lymphomas. Although these cancers start in the skin, they originate in the white blood cells, called lymphocytes thus classifying them as blood cancers. The two main types of lymphocytes that can develop into cutaneous lymphoma cancers, the T-cells and B-cells, with the former being the most common. The EORTC Group works with the pharmaceutical industry and its Translational Researchers to find targeted treatments for patients affected by this cancer type. They also actively engage in research to identify the prognosis and predicting factors of the disease.